Navigation Links
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
Date:5/4/2009

al are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We can not guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors and Other Uncertainties" section of our Form 20-F lodged with the U.S. Securities and Exchange Commission.

    CONTACT:

     Alan Robertson
     Chief Executive Officer
     Tel:   +61-2-9454-7200
     Email: alan.robertson@pharmaxis.com.au

    RELEASED THROUGH:

     Australia:
     Felicity Moffatt
     Tel:   +61-418-677-701
     Email: felicity.moffatt@pharmaxis.com.au

     United States:
     Brandon Lewis
     Trout Group
     Tel:   +1-646-378-2915
     Email: blewis@troutgroup.com

'/>"/>
SOURCE Pharmaxis Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
2. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
3. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
4. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
5. Pharmaxis Establishes Named Patient Program for Bronchitol
6. Pharmaxis Long-Term Safety Study of Bronchitol Completes
7. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
8. Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
9. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
10. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
11. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Medical announces the formal launch of the largest ... on the market today at this weekend,s American Orthopaedic ... Chicago .  The Osteotomy Truss System is a comprehensive ... size options included in one versatile set. Previously available ... 18 implant sizes, which limited a surgeon,s ability to ...
(Date:9/19/2014)... Sept. 19, 2014  Diplomat, the nation,s largest independent ... Dreyer to the Board of Directors on September ... will also serve as chair of the Audit Committee. ... of accounting, financial, compliance and operating experience in the ... served as chief financial officer, chief operating officer and ...
(Date:9/19/2014)... , September 19, 2014 ... by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), ... Technology (Tray-style, Manifold, & Rotary) & Geography - ... MarketsandMarkets, defines and segments the lyophilization market on ... with analyses and projections of the market size ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2David Dreyer Appointed to Diplomat Board of Directors 2Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3
... Robbins & Myers, Inc. (NYSE: RBN ) announced today that its Board of Directors approved a regular cash dividend payment of $0.0425 per share. , ... , , ... ... The dividend is payable on May 7, 2010 to shareholders of record as of ...
... Clinicians Temporarily Suspend Use of Vaccine as Agency Learns More , ... , , ... ... SILVER SPRING, Md. , March ...
Cached Medicine Technology:Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk 2Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk 3Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk 4
(Date:9/21/2014)... While public health authorities focus on the physical activity ... University of Montreal reveals that for children, playing has ... an activity that is fun, done alone or with ... or pleasure, but also to combat boredom, sadness, fear, ... of play, authorities put aside several aspects of play ...
(Date:9/21/2014)... PhUSE is proud to announce Dr. Pritpal ... keynote speakers for their 10th annual conference which is ... Goldacre in 2013 , Charles Sabine in 2012 ... PhUSE again presents high-calibre speakers to talk about relevant ... clinical information. , Dr. Pritpal Tamber is a "health ...
(Date:9/21/2014)... BC (PRWEB) September 21, 2014 Burnaby ... educational information to clients in order to help them ... sessions held at the clinic that will help clients ... they can also take active participation in the healing ... and posture, clients will be able to facilitate the ...
(Date:9/21/2014)... 21, 2014 The Laboratory Testing Services ... manufacturers perform tests on items ranging from consumer and ... society, pressure on operators to ensure the safety and ... greater number of government safety regulations and consumer lawsuits ... to sale. Although revenue briefly dipped in 2009 as ...
(Date:9/21/2014)... New York, NY (PRWEB) September 21, 2014 ... has enabled more generic drugs to inundate the market, ... Name Pharmaceutical Manufacturing industry. According to data from ... drugs has cost the industry $1.8 and $2.5 billion ... blockbuster, brand-name drugs losing patent exclusivity, which has hampered ...
Breaking Medicine News(10 mins):Health News:Narrow focus on physical activity could be ruining kids' playtime 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 3Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3
... demonstrated that our own experience is important to exhibit feelings ... been working hard to understand what happens in our brain ... The results of the observation show that the actions of ... ,The research points out that we understand the actions ...
... Reports from World Health Organization (WHO), shows that 36 million ... heart diseases, stroke, cancer and diabetes and serious measures has ... 10 years. The main factors which are responsible for the ... exercise, people eating more food rich in fats and sugars, ...
... as it is commonly known is a silent killer because ... disease. However, it can lead to a lot of complications ... left untreated. Fortunately, it can be diagnosed by a very ... anti-hypertensive medication., ,Two inexpensive, but widely overlooked drugs may ...
... the dilemmas of geographical separation between the doctor and ... the feasibility of telephone consultation as an alternative method ... for busy patients and may save costs. Telemedicine has ... medical information and services., ,Successful communication is based ...
... One of the biggest challenges in the delivery of ... primary health centres (PHCs) and community health centres (CHCs) ... lack of basic amenities and incentives. An important reason ... of accountability in our public health services. While the ...
... Human papillomavirus (HPV) is one of the most common causes ... 100 different types of HPV exist, most of which are ... // membranes, causing warts to grow in the anal, genital, ... or venereal warts are the most easily recognized sign of ...
Cached Medicine News:Health News:Feelings Of Sympathy And Empathy Dictated by Personal Experience 2Health News:Feelings Of Sympathy And Empathy Dictated by Personal Experience 3Health News:Common, cheaper drugs could be used to treat hypertension 2Health News:Medical Mishaps In Telemedicine And Their Prevention 2Health News:Problems in rural health delivery and remedies 2
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
... that quantitatively measure two important cardiac risk ... serum or plasma homocysteine level is increasingly ... factor for cardiovascular disease. And numerous studies ... levels of Lp(a) with increased risk of ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
Medicine Products: